Israel - hebraico - Ministry of Health

novartis pharma services ag - metformin hydrochloride 500 mg; vildagliptin 50 mg - film coated tablets - metformin - eucreas is indicated in the treatment of type 2 diabetes mellitus patients who are unable to achieve sufficient glycaemic control at their maximally tolerated dose of oral metformin alone or who are already treated with the combination of vildagliptin and metformin as separate tablets.

Israel - hebraico - Ministry of Health

novartis pharma services ag - vildagliptin 50 mg - tablets - vildagliptin - galvus is indicated as an adjunct to diet and exercise in patients with type 2 diabetes mellitus• as monotherapy, if diet and exercise are not sufficient, or• in combination with metformin, or a sulfonylurea if treatment with these oral antidiabetics does not offer sufficient control of blood glucose.as triple oral therapy in combination with• a sulphonylurea and metformin when diet and exercise plus dual therapy with these agents do not provide adequate glycaemic control. galvus is also indicated for use in combination with insulin (with or without metformin) when diet and exercise plus a stable dose of insulin do not provide adequate glycaemic control.

Israel - hebraico - Ministry of Health

novartis pharma services ag - vildagliptin 50 mg - tablets - vildagliptin - galvus is indicated as an adjunct to diet and exercise in patients with type 2 diabetes mellitus• as monotherapy, if diet and exercise are not sufficient, or• in combination with metformin, or a sulfonylurea if treatment with these oral antidiabetics does not offer sufficient control of blood glucose.as triple oral therapy in combination with• a sulphonylurea and metformin when diet and exercise plus dual therapy with these agents do not provide adequate glycaemic control. galvus is also indicated for use in combination with insulin (with or without metformin) when diet and exercise plus a stable dose of insulin do not provide adequate glycaemic control.

Israel - hebraico - Ministry of Health

novartis pharma services ag - potassium chloride 600 mg - tablets slow release - potassium chloride - treatment and prevention of hypokalaemia.

Israel - hebraico - Ministry of Health

novartis pharma services ag - potassium chloride 600 mg - tablets slow release - potassium chloride - treatment and prevention of hypokalaemia.

Israel - hebraico - Ministry of Health

novartis pharma services ag - acenocoumarol 4 mg - tablets - acenocoumarol - anticoagulant derived from coumarin.

Israel - hebraico - Ministry of Health

novartis pharma services ag - glyceryl trinitrate 25 mg/patch - patches - glyceryl trinitrate - prophylaxis of angina pectoris.

Israel - hebraico - Ministry of Health

novartis pharma services ag - glyceryl trinitrate 25 mg/patch - patches - glyceryl trinitrate - prophylaxis of angina pectoris.

Israel - hebraico - Ministry of Health

novartis pharma services ag - glyceryl trinitrate 50 mg/patch - patches - glyceryl trinitrate - prophylaxis of angina pectoris.

Israel - hebraico - Ministry of Health

novartis pharma services ag - glyceryl trinitrate 50 mg/patch - patches - glyceryl trinitrate - prophylaxis of angina pectoris.